Thomas R. Parr
Keine laufenden Positionen mehr
Profil
Thomas R.
Parr worked as President & Acting Chief Executive Officer at MicroGenomics, Inc. and as Senior Director-Microbiology at IntraBiotics Pharmaceuticals, Inc. and Xenogen Corp.
He was also the Chief Scientific Officer & Head-Montreal Site at Targanta Therapeutics Corp.
and Chief Scientific Officer at Targanta Therapeutics, Inc. Additionally, he worked as Vice President-Research at Adaptive Therapeutics, Inc. and as Principal at Lilly Research Laboratories.
He is currently the Chief Scientific Officer at Spero Therapeutics, Inc. Prior to his career in industry, he was an Assistant Professor at the University of Ottawa.
He received his undergraduate degree from the University of Minnesota and his graduate and doctorate degrees from the University of Calgary.
Ehemalige bekannte Positionen von Thomas R. Parr
| Unternehmen | Position | Ende |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.07.2022 |
| Fedora Pharmaceuticals, Inc. | Chief Tech/Sci/R&D Officer | 01.01.2014 |
Adaptive Therapeutics, Inc.
 Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adaptive Therapeutics, Inc. develops pharmaceutical products. It develops drugs for applications in anti-bacterial, fungal, viral, and cancer therapeutics. The company was founded in 2002 and is headquartered in San Diego, CA | Chief Tech/Sci/R&D Officer | 01.12.2004 |
MicroGenomics, Inc.
 MicroGenomics, Inc. Miscellaneous Commercial ServicesCommercial Services MicroGenomics, Inc. develops technology to uncover molecular and genetic diversity in microorganisms that can not be cultured in the laboratory. The company is headquartered in Solana Beach, CA. | President | 01.05.2003 |
Xenogen Corp.
 Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Corporate Officer/Principal | 01.03.2002 |
Ausbildung von Thomas R. Parr
| University of Minnesota | Undergraduate Degree |
| University of Calgary | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Essential Therapeutics, Inc.
 Essential Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Essential Therapeutics, Inc. manufactures pharmaceutical goods for viral and fungal infections | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Xenogen Corp.
Xenogen Corp. Medical SpecialtiesHealth Technology Xenogen Corp. provides real time in-vivo imaging services and genetic modification technologies. Its products and technologies include an imaging system, software, and biological materials. Its solutions are designed to improve discovery and pre-clinical research in multiple therapeutic areas. The company was founded by Pamela Reilly Contag and Christopher H. Contag in 1995 and is headquartered in Alameda, CA. | Health Technology |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Targanta Therapeutics Corp. discovers and develops novel antibacterial pro drugs. The company was founded in 1997 and is headquartered in Parsippany, NJ. | Health Technology |
| Fedora Pharmaceuticals, Inc. | |
MicroGenomics, Inc.
MicroGenomics, Inc. Miscellaneous Commercial ServicesCommercial Services MicroGenomics, Inc. develops technology to uncover molecular and genetic diversity in microorganisms that can not be cultured in the laboratory. The company is headquartered in Solana Beach, CA. | Commercial Services |
Targanta Therapeutics, Inc.
 Targanta Therapeutics, Inc. BiotechnologyHealth Technology Targanta Therapeutics, Inc. develops antibiotic drugs and other related products. It focuses on developing and commercializing novel antibacterial agents to address unmet medical needs in the hospital market. The company also develops antibacterial pro-drugs for the treatment and prevention of bone infections. Targanta Therapeutics was founded in May 2007 and is located in St. Laurent, Canada | Health Technology |
Adaptive Therapeutics, Inc.
Adaptive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adaptive Therapeutics, Inc. develops pharmaceutical products. It develops drugs for applications in anti-bacterial, fungal, viral, and cancer therapeutics. The company was founded in 2002 and is headquartered in San Diego, CA | Health Technology |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a private company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Commercial Services |
